Birmingham research shapes new miscarriage guidelines

Research led by BHP founder-member the University of Birmingham has helped to shape guidelines which could mean thousands of women with prior miscarriage, and bleeding in early pregnancy, could be eligible for treatment with progesterone each year. The updated guidance, announced today by the National Institute for Health and Care Excellence (NICE), follows a review of evidence … Continue reading “Birmingham research shapes new miscarriage guidelines”

Science is thriving in UK regions: Government must back them

The government, academia, and industry leaders must work together to support and develop regional life science ecosystems to meet the double ambitions of making the UK a global science superpower and levelling up the country to provide opportunity for all. A new report published today by the Association of the British Pharmaceutical Industry (ABPI), Birmingham … Continue reading “Science is thriving in UK regions: Government must back them”

New programme to train future mental health and neuroscience professionals

Future healthcare professionals working in mental health and neurosciences will be trained at a new Doctoral Training Programme (DTP) thanks to a multi-million award from Wellcome. Led by the University of Nottingham, the new DTP is a collaboration between the Universities of Nottingham, Leicester, Birmingham and Warwick. Wellcome has awarded over £7.24 million to the University of … Continue reading “New programme to train future mental health and neuroscience professionals”

Birmingham to commercialise anti-viral nasal spray against COVID-19

Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and BHP founder-member the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19. COVID-19 is both contracted and transmitted by inhalation of droplets or aerosols containing the SARS-CoV-2 virus, and … Continue reading “Birmingham to commercialise anti-viral nasal spray against COVID-19”

Non-invasive ventilation for COVID-19 patients isn’t linked to heightened infection risk

New research carried out in collaboration with the University of Birmingham has found that the use of non-invasive breathing support to treat patients with moderate to severe COVID-19 in hospitals isn’t linked to a heightened risk of transmitting infection to others as had previously been thought. The use of non-invasive breathing support, called continuous positive … Continue reading “Non-invasive ventilation for COVID-19 patients isn’t linked to heightened infection risk”